Achieved 30-patient recruitment milestone in Phase 3 vilobelimab trial in pyoderma gangrenosum (PG) to enable interim ...

Koppers Holdings Inc. , an integrated global provider of treated wood products, wood treatment chemicals, and carbon compounds, today reported net income attributable to Koppers for the third quarter ...

Key financial results, reported in U.S. dollars ("USD"), for the thirty-nine weeks ended September 28, 2024, or Fiscal 2024, are as follows (unless otherwise noted, all comparisons are relative to the ...

Record Third Quarter Sales of $554.3 Million vs. $550.4 Million in Prior Year Quarter Third Quarter Diluted EPS of $1.09 vs. $1.22 in Prior Year Quarter Adjusted EPS ...